2-(1,1-Difluoroethyl)pyridin-4-amine, 98%, 100mg

(2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid, 95.0%, 250mg

tert-Butyl ((3S,4S)-7-cyano-4-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)carbamate, 98%, 100mg

Dimethyloxalate, 99.0%, 100g

DBD-CO-Hz [=4-(N,N-Dimethylaminosulfonyl)-7-(N-hydrazinocarbonylmethyl-N-methyl)amino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

6-Bromo-4-nitropicolinic acid, 97%, 1g

5-Boc-2-bromo-6,7-dihydro-4H-thiazolo[5,4-c]pyridine, 95.0%, 25g

(Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(2-methylacrylate), 95.0%, 100g

5-Bromouracil, 97.0%, 10g

1-(METHANESULFONYLMETHYL)-4-NITROBENZENE, 95.0%, 250mg

4-((tert-Butoxycarbonyl)amino)-2-chlorobenzoic acid, 97%, 1g

Boc-5-amino-2-methoxybenzoic acid, 99.0%, 25g

Ethyl Chloroglyoxylate>98.0%(T)500g